Beam Therapeutics Inc. (NASDAQ: BEAM)
| Pre-Market | Intra-Day | After-Hours |
|---|---|---|
| - (- / -%) | 34.14 (1.66 / 5.11%) | 34.26 (0.12 / 0.35%) |
| - | 18-Jun 16:00 | 18-Jun 19:05 |
Sector: Healthcare || Industry: Biotechnology
| Previous Close | 32.48 | Year Low | 15.60 |
| Open | 33.58 | Year High | 36.44 |
| Day Low | 32.66 | Price Avg 50 | 29.99 |
| Day High | 34.35 | Price Avg 200 | 26.91 |
| Volume | 2.74 M | Market Cap | 3.51 B |
News
| Symbol | Catalyst News |
|---|---|
| BEAM | Beam Therapeutics (BEAM) Gets FDA Nod for BEAM-304 Trial Catalyst picR | 2026-06-18 08:20:15 Beam Therapeutics Stock Soars 21% in Three Months: Here's Why Zacks Investment Research | 2026-06-16 09:51:26 3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2026 Zacks Investment Research | 2026-06-02 13:10:18 Beam Therapeutics Eyes Sickle Cell BLA as Alpha-1 Gene-Editing Program Advances MarketBeat | 2026-05-20 14:05:29 Hedge Fund Drops $40 Million on Gene-Editing Biotech Beam. Is It a Buy? Fool - Investing News | 2026-05-18 14:05:44 Beam Therapeutics: Base Editing Is Moving From Platform Story To Regulatory Asset Story Seeking Alpha | 2026-05-13 09:46:02 BEAM's Q1 Loss Wider Than Expected, Revenues Beat Estimates Zacks Investment Research | 2026-05-08 13:11:19 Beam Therapeutics Inc. (BEAM) Reports Q1 Loss, Beats Revenue Estimates Zacks Investment Research | 2026-05-07 09:56:27 |
Analysis
| Symbol | 1D | 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|---|---|
| BEAM | 5.11 | 15.89 | 27.34 | 34.83 | 30.45 | 100.94 |
Earnings
| Date | Time | Symbol | company_name | Period | Metric | Estimate | Actual | Surprise | YrAgo | Growth | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/07/2026 | BMO | BEAM | Beam Therapeutics | Q1 2026 | EPS | -1.09 | -0.91 | 16.51 | -1.24 | 26.60 | |
| 05/07/2026 | BMO | BEAM | Beam Therapeutics | Q1 2026 | REV | 10.98 M | 31.74 M | 189.13 | 7.47 M | 324.87 | |
| 02/24/2026 | BMO | BEAM | Beam Therapeutics | Q4 2025 | EPS | -0.99 | -0.10 | 89.90 | -1.09 | 90.80 | |
| 02/24/2026 | BMO | BEAM | Beam Therapeutics | Q4 2025 | REV | 12.57 M | 114.11 M | 808.01 | 30.07 M | 279.48 | |
| 11/04/2025 | BMO | BEAM | Beam Therapeutics | Q3 2025 | EPS | -1.04 | -1.10 | -5.77 | -1.17 | 6.00 | |
| 11/04/2025 | BMO | BEAM | Beam Therapeutics | Q3 2025 | REV | 12.37 M | 9.70 M | -21.59 | 14.27 M | -32.03 | |
| 08/05/2025 | BMO | BEAM | Beam Therapeutics | Q2 2025 | EPS | -1.11 | -1.00 | 9.91 | -1.11 | 9.90 | |
| 08/05/2025 | BMO | BEAM | Beam Therapeutics | Q2 2025 | REV | 13.56 M | 8.47 M | -37.58 | 11.77 M | -28.08 |
Outlooks
| Date | Time | Symbol | Company | Period | Metric | Estimate | Outlook | Previous | Catalyst | list_link | eps_est | rev_est | cur_midpoint | pre_midpoint | Growth * | yrago_growth | pre_growth | company_sector | company_industry | ref_id | chart_code | history_code | sector_industry |
|---|
Ratings
| Date | Symbol | Analyst Firm | Rating Current | Rating Previous | Analyst Action |
|---|---|---|---|---|---|
| 03/26/2026 | BEAM | Citigroup | Buy | Buy | Maintain |
| 02/25/2026 | BEAM | RBC Capital | Sector Perform | Sector Perform | Maintain |
| 02/25/2026 | BEAM | Wedbush | Outperform | Outperform | Maintain |
| 01/21/2026 | BEAM | Bernstein | Outperform | Outperform | Maintain |
Dividends
| Date | Symbol | Company | Type | Value | Yield | Record Date | Exch Date | Pay Date | Notes |
|---|
Sign-Up to see the full list of CATALYSTS in the Calendars
